Evidence map›Paper›PMID 24523408›Full record

ArticleThe Journal of biological chemistry2014

Tudor-SN, a novel coactivator of peroxisome proliferator-activated receptor γ protein, is essential for adipogenesis.

Zhongchao Duan, Xiujuan Zhao, Xiao Fu, Chao Su, Lingbiao Xin, Juha Saarikettu, Xi Yang, Zhi Yao, Olli Silvennoinen, Minxin Wei and 1 more

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
2.3field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 45 citations in OpenAlex.

  1. Article
  2. LncRNAeLife · 2024
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Insights IntoFrontiers in oncology · 2018
    Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 5 countries.

Zhongchao DuanFrom the Department of Biochemistry and Molecular Biology, Department of Immunology, School of Basic Medical Sciences.
Xiujuan Zhao
Xiao Fu
Chao Su
Lingbiao Xin
Juha Saarikettu
Xi Yang
Zhi Yao
Olli Silvennoinen
Minxin Wei
Jie Yang
Tianjin Medical University · CNCenter of Molecular Immunology (Cuba) · CUTianjin Medical University General Hospital · CNLaboratory of Molecular Genetics · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Adipogenesis, in which mesenchymal precursor cells differentiate into mature adipocytes, is a well orchestrated process. In the present study we identified Tudor-SN as a novel co-activator of the transcription factor peroxisome proliferator-activated receptor γ (PPARγ). We provide the first evidence that Tudor-SN and PPARγ exist in the same complex. Both are up-regulated by the early factor C/EBPβ during adipogenesis and significantly influence the regulation of PPARγ target genes in both 3T3-L1 pre-adipocyte and mouse embryonic fibroblasts (MEF) upon exposure to a mixture of hormonal mixture. Moreover, aP2-PPARγ response element (PPRE) interacts with both PPARγ and Tudor-SN, and the gene transcriptional activation of PPRE-luc is enhanced by ectopic expression of Tudor-SN. Deletion of Tudor-SN protein (MEF-KO) affects but does not completely abolish the association of PPARγ and aP2-PPRE. Loss-of-function studies further verified that Tudor-SN is required for adipogenesis, as deletion of Tudor-SN (MEF-KO) impairs dexamethasone, 3-isobutyl-1-methylxanthine, and insulin (DMI)-induced adipocyte differentiation and the expression of PPARγ target genes, such as aP2 and adipsin. Furthermore, H3 acetylation levels were lower in MEF-KO than MEF-WT. Both HDAC1 and HDAC3 are stably associated with PPARγ in MEF-KO, whereas only a small amount of association was observed in MEF-WT after 5 days of treatment during adipogenesis. PPARγ requires various co-activators or co-repressors, which may dynamically associate with and regulate the higher order chromatin remodeling of the promoter region of PPARγ-bound target genes; Tudor-SN is likely one of these co-activators.

Indexed as

Adipogenesis3T3-L1 CellsAdipocytesAnimalsCCAAT-Enhancer-Binding Protein-betaCells, CulturedEndonucleasesGene DeletionGene Expression Regulation, DevelopmentalHumansMiceMice, Inbred C57BLNuclear ProteinsPPAR gammaUp-RegulationCCAAT-Enhancer-Binding Protein-betaEndonucleasesNuclear ProteinsPPAR gammaSnd1 protein, mouseAdipogenesisC/EBP Transcription FactorC/EBPβHDACHistone DeacetylaseHistone ModificationPeroxisome Proliferator-activated Receptor (PPAR)PPARγTudor-SN

Identifiers

PMID24523408
PMCPMC3961662
OpenAlexW2057953609

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.